KetoProPig 100mg/ml Oral Solution for Pigs
Country: Italja
Lingwa: Ingliż
Sors: HMA (Heads of Medicines Agencies)
Karatteristiċi tal-prodott
(SPC)
29-06-2013
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
ketoprofen 10 g
Disponibbli minn:
Fort Dodge Animal Health
Kodiċi ATC:
QM01AE03
Għamla farmaċewtika:
Oral solution
Grupp terapewtiku:
ketoprofen
Żona terapewtika:
Pigs
Data ta 'l-awtorizzazzjoni:
2011-07-10
Karatteristiċi tal-prodott
Revised: November 2011
AN: 01317/2011
Page 1 of 8
SUMMARY OF THE PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
KetoProPig 100 mg/ml Oral Solution for use in drinking water for Pigs
KeProPig 100 mg/ml Oral Solution for use in drinking water for Pigs (ES and
PO)
2.
QUALITATIVE AND QUANITIATIVE COMPOSITION
Each ml contains:
Active substance
Ketoprofen:
100 mg
Excipients
Benzyl Alcohol:
20 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral solution
Transparent and colourless liquid.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Fattening Pigs
4.2
INDICATIONS FOR USE
Symptomatic treatment for reduction of pyrexia in cases of acute infectious
respiratory disease in fattening pigs in combination with an appropriate anti -
infective therapy_._
4.3
CONTRA-INDICATIONS
Do not use in case of hypersensitivity to ketoprofen.
Do not use in animals known to be allergic to aspirin.
Do not use in pregnant animals.
Do not use in pigs already suffering from gastric ulcers, in order not to aggravate
their situation.
Revised: November 2011
AN: 01317/2011
Page 2 of 8
Revised: November 2011
AN: 01317/2011
Page 3 of 8
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Avoid use in dehydrated, hypovolaemic or hypotensive pigs as there is a
potential risk of increased renal toxicity.
Use in very young animals may involve additional risk: however, if used,
animals require careful clinical management.
As ketoprofen is ulcerogenic, the use is not recommended in case of PMWS
(Post-weaning multisystemic wasting syndrome) because ulcers are already
frequently associated with
Aqra d-dokument sħiħ
